Jean de Gunzburg, PhD

Doctor
Da Volterra, Paris, France

Disclosure: Da Volterra (Board Member, Consultant, Shareholder)

Presentation(s):

• LB-5 - DAV132 Protects Intestinal Microbiota of Patients Treated with Quinolones, a European Phase II Randomized Controlled Trial (SHIELD)

  Saturday, October 24, 2020
  10:30am – 10:40am EDT